OC
SNDX icon

Oppenheimer & Co’s Syndax Pharmaceuticals SNDX Stock Holding History

Oppenheimer & Co’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-19,809
Closed -$88K – 1387
2018
Q4 		$88K Buy
19,809
+221
+1% +$1.21K ﹤0.01% 1191
2018
Q3 		$158K Buy
19,588
+4,311
+28% +$30.7K ﹤0.01% 1268
2018
Q2 		$107K Sell
15,277
-1,374
-8% -$13.5K ﹤0.01% 1287
2018
Q1 		$237K Buy
16,651
+2,191
+15% +$23.3K 0.01% 1155
2017
Q4 		$127K Sell
14,460
-13,335
-48% -$132K ﹤0.01% 1262
2017
Q3 		$325K Buy
27,795
+1,296
+5% +$15.9K 0.01% 1006
2017
Q2 		$370K Sell
26,499
-95
-0.4% -$1.09K 0.01% 939
2017
Q1 		$365K Buy
+26,594
New +$276K 0.01% 922

Other funds holding SNDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return